Back

Extracellular volume fraction by computed tomography predicts long-term prognosis among patients with cardiac amyloidosis

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Applying software technology in modern cardiovascular computed tomography Myocardial Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Francisco Fernandes Gama

Hospital de Santa Cruz, Carnaxide (Portugal)

4 More presentations in this session

Presentation thumbnail
Association between epicardial adipose tissue and recurrence after atrial fibrillation catheter ablation
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
A deep-learning approach for scar detection in early contrast-enhanced cardiac computed tomography images
Doctor M. Babbaro (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Anatomic and functional discordance among patients with non-obstructive coronary disease
Doctor J. Rymer (Durham, US)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of computed tomography myocardial perfusion to detect coexisting microvascular dysfunction in patients with obstructive epicardial coronary disease
Doctor T. Nagamine (Ibaraki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Applying software technology in modern cardiovascular computed tomography

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Discussant review - CA-AI Echo (Cardiac Amyloidosis-Artificial Intelligence Echo)
thumbnail
Congress Presentation
Cardiac amyloidosis and heart failure phenotypes: a prognostic study of systolic function markers
thumbnail
Congress Presentation
Comparative assessment of extracellular volume metrics in predicting adverse outcomes in patients with transthyretin amyloid cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources